Shanghai Hutchison Pharmaceuticals Limited
Clinical trials sponsored by Shanghai Hutchison Pharmaceuticals Limited, explained in plain language.
-
Herbal pill shows promise for neck nerve pain in new trial
Disease control CompletedThis study tested whether a Chinese herbal pill called Shenqi Sherong Pill can help people with mild to moderate cervical spondylotic myelopathy, a condition where the spinal cord in the neck is compressed. 428 adults aged 18-75 took either the herbal pill or a placebo three time…
Phase: PHASE3 • Sponsor: Shanghai Hutchison Pharmaceuticals Limited • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New stroke drug shows promise in early trial
Disease control CompletedThis study tested a new drug called SHPL-49 in 270 people who had an acute ischemic stroke. Participants received either the drug or a placebo as an IV infusion twice daily for 7 days. The goal was to see if the drug helps improve recovery and is safe to use.
Phase: PHASE2 • Sponsor: Shanghai Hutchison Pharmaceuticals Limited • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC